Covid-19 outbreak drew the progressive economy towards regression, but later
with India being seen as a prime investment destination over China exacerbating
the current scenario, there is a comeback of the failed campaign ‘Make In
India’ to light, with global pharmaceuticals companies eyeing on India.
Therefore there emerges a need for Make In India to be catering not just the
pharmaceutical companies, but it is the right time to cater to other companies,
as well, in various sectors to look at
India as a profitable destination.